Inhibikase Therapeutics, Inc.
IKT
←Back to Recent Filings

Filing DATE FP FY End Date URL VIEW
WIREPR 11/14/2024 3 2024 9/30/2024 WIRE view data
10-Q 11/14/2024 3 2024 9/30/2024 SEC view
WIREPR 8/14/2024 2 2024 6/30/2024 WIRE view data
10-Q 8/14/2024 2 2024 6/30/2024 SEC view
WIREPR 5/15/2024 1 2024 3/31/2024 WIRE view data
10-Q 5/15/2024 1 2024 3/31/2024 SEC view
WIREPR 3/27/2024 4 2023 12/31/2023 WIRE view data
10-K 3/27/2024 4 2023 12/31/2023 SEC view
WIREPR 11/14/2023 3 2023 9/30/2023 WIRE view data
10-Q 11/14/2023 3 2023 9/30/2023 SEC view
10-K/A 10/16/2023 4 2022 12/31/2022 SEC view
WIREPR 8/14/2023 2 2023 6/30/2023 WIRE view data
10-Q 8/14/2023 2 2023 6/30/2023 SEC view
WIREPR 5/15/2023 1 2023 3/31/2023 WIRE view data
10-Q 5/15/2023 1 2023 3/31/2023 SEC view
WIREPR 3/31/2023 1 2023 3/31/2023 WIRE view data
10-K 3/31/2023 4 2022 12/31/2022 SEC view
POS AM 3/31/2023 4 2022 12/31/2022 SEC view
S-1 2/2/2023 3 2022 9/30/2022 SEC view
8-K 11/17/2022 3 2022 9/30/2022 SEC view data
10-Q 11/14/2022 3 2022 9/30/2022 SEC view
WIREPR 8/12/2022 2 2022 6/30/2022 WIRE view data
10-Q 8/12/2022 2 2022 6/30/2022 SEC view
WIREPR 5/16/2022 1 2022 3/31/2022 WIRE view data
10-Q 5/16/2022 1 2022 3/31/2022 SEC view
WIREPR 3/31/2022 4 2021 12/31/2021 WIRE view data
10-K 3/31/2022 4 2021 12/31/2021 SEC view
WIREPR 11/15/2021 3 2021 9/30/2021 WIRE view data
10-Q 11/15/2021 3 2021 9/30/2021 SEC view
WIREPR 8/16/2021 2 2021 6/30/2021 WIRE view data
10-Q 8/16/2021 2 2021 6/30/2021 SEC view
S-1 6/11/2021 1 2021 3/31/2021 SEC view
10-Q 5/17/2021 1 2021 3/31/2021 SEC view
8-K 4/1/2021 1 2021 3/31/2021 SEC view data